Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TAF15 amyloids propagate via defined motifs in a prion-like fashion.

Nature communications·2026
Same author

Comorbid neuropathologies but not Braak stage influence cognitive impairment in primary age-related tauopathy.

Journal of neuropathology and experimental neurology·2026
Same author

Single-nucleus transcriptomics identifies a shared vulnerable excitatory neuronal population across typical and atypical Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Cysteines are critical determinants of spontaneous and seeded tau aggregation in cells.

bioRxiv : the preprint server for biology·2026
Same author

A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Nature genetics·2026
Same author

Classification of tauopathies from human brain homogenates through salt-modulated tau amplification.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: May 8, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Globular glial tauopathies (GGT): consensus recommendations.

Zeshan Ahmed1, Eileen H Bigio2, Herbert Budka3

  • 1Department of Molecular Neuroscience, Queen Square Brain Bank, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.

Acta Neuropathologica
|September 3, 2013
PubMed
Summary

Neuropathologists propose a new classification for globular glial tauopathy (GGT), a rare tauopathy characterized by globular glial inclusions (GGIs). This consensus aims to standardize terminology for these neurodegenerative diseases.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Related Experiment Videos

Last Updated: May 8, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Tauopathies

Background:

  • Recent studies identify 4-repeat (4R) tauopathies characterized by globular glial inclusions (GGIs).
  • These tauopathies exhibit heterogeneous clinicopathological features and varied clinical presentations.
  • Existing terminology for GGI-characterized cases is inconsistent and redundant, hindering research and diagnosis.

Purpose of the Study:

  • To establish a consensus on the terminology and classification of tauopathies with globular glial inclusions (GGIs).
  • To propose a unified term and subtypes for this distinct disease entity.
  • To facilitate future diagnostic research criteria development.

Main Methods:

  • A panel of experienced neuropathologists reviewed microscopic images from 22 previously reported cases with suspected GGIs.
  • Consensus was reached on the presence, morphology, and classification of GGIs and associated astrocytic inclusions.
  • Cases were analyzed for neuropathological subtypes and their correlation with clinical presentations.

Main Results:

  • All reviewed cases confirmed the presence of GGIs.
  • The morphology of globular astrocytic inclusions was distinguished from tufted astrocytes.
  • Three neuropathopathological subtypes (Type I, II, III) of globular glial tauopathy (GGT) were identified, each with distinct clinical and pathological features.
  • Significant white matter degeneration was a common feature across all GGT subtypes.

Conclusions:

  • The term globular glial tauopathy (GGT) is proposed as an overarching classification for these cases.
  • GGT represents a spectrum of a distinct disease entity, with identified subtypes correlating to specific clinical syndromes.
  • Standardized terminology and classification are crucial for advancing research and establishing diagnostic criteria for GGT.